患有慢性淋巴细胞白血病和其他惰的B细胞淋巴细胞恶性瘤的患者的伯基特淋巴瘤

Tadeusz Robak1,2, Agnieszka Pluta1,3, Pawel Robak1

  • 1Department of Hematology, Medical University of Lodz, Lodz, Poland.

Leukemia & lymphoma
|March 25, 2025
PubMed
概括

这项研究检查慢性淋巴细胞白血病 (CLL) 转化为伯基特淋巴瘤 (BL),这是一个罕见的事件. 它回顾了病例,并讨论了BL转变在惰的B细胞淋巴细胞恶性瘤中的发病,预后和治疗.

相关概念视频

Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
820
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
374
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K